These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15048723)

  • 1. Involvement of NKR-P2/NKG2D in DC-mediated killing of tumor targets: indicative of a common, innate, target-recognition paradigm?
    Alli R; Savithri B; Das S; Varalakshmi C; Rangaraj N; Khar A
    Eur J Immunol; 2004 Apr; 34(4):1119-26. PubMed ID: 15048723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response.
    Srivastava RM; Varalakshmi Ch; Khar A
    Int Immunol; 2007 May; 19(5):591-607. PubMed ID: 17369187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B; Khar A
    Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation.
    Srivastava RM; Varalakshmi C; Khar A
    J Immunol; 2008 Jan; 180(2):1117-30. PubMed ID: 18178852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
    Kanazawa N
    J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dendritic cell subset involved in tumor immunosurveillance.
    Taieb J; Chaput N; Ménard C; Apetoh L; Ullrich E; Bonmort M; Péquignot M; Casares N; Terme M; Flament C; Opolon P; Lecluse Y; Métivier D; Tomasello E; Vivier E; Ghiringhelli F; Martin F; Klatzmann D; Poynard T; Tursz T; Raposo G; Yagita H; Ryffel B; Kroemer G; Zitvogel L
    Nat Med; 2006 Feb; 12(2):214-9. PubMed ID: 16444265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1.
    Kaden SA; Kurig S; Vasters K; Hofmann K; Zaenker KS; Schmitz J; Winkels G
    J Immunol; 2009 Oct; 183(8):5069-78. PubMed ID: 19786536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion.
    Höpken UE; Lehmann I; Droese J; Lipp M; Schüler T; Rehm A
    Eur J Immunol; 2005 Oct; 35(10):2851-63. PubMed ID: 16180253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses.
    Lahoud MH; Proietto AI; Ahmet F; Kitsoulis S; Eidsmo L; Wu L; Sathe P; Pietersz S; Chang HW; Walker ID; Maraskovsky E; Braley H; Lew AM; Wright MD; Heath WR; Shortman K; Caminschi I
    J Immunol; 2009 Jun; 182(12):7587-94. PubMed ID: 19494282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
    Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response.
    Gosset P; Pichavant M; Faveeuw C; Bureau F; Tonnel AB; Trottein F
    Eur J Immunol; 2005 May; 35(5):1491-500. PubMed ID: 15816013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two major groups of rat NKR-P1 receptors can be distinguished based on chromosomal localization, phylogenetic analysis and Clr ligand binding.
    Kveberg L; Dai KZ; Westgaard IH; Daws MR; Fossum S; Naper C; Vaage JT
    Eur J Immunol; 2009 Feb; 39(2):541-51. PubMed ID: 19130483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing immune responses by targeting antigen to DC.
    Caminschi I; Lahoud MH; Shortman K
    Eur J Immunol; 2009 Apr; 39(4):931-8. PubMed ID: 19197943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
    Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.